NF1 and nerve sheath neoplasm: Currently, the sole FDA-approved drug treatment for NF1-associated inoperable plexiform neurofibromas is the MEK inhibitor selumetinib [6,7,8], which is indicated for the treatment of pediatric (but not adult) NF1-associated nerve sheath tumors.